- Home
- QIPT vs GUTS Comparison
QIPT vs GUTS Comparison
Compare QIPT & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QIPT
- GUTS
- Stock Information
- Founded
- QIPT 1993
- GUTS 2010
- Country
- QIPT United States
- GUTS United States
- Employees
- QIPT N/A
- GUTS N/A
- Industry
- QIPT
- GUTS
- Sector
- QIPT
- GUTS
- Exchange
- QIPT Nasdaq
- GUTS NYSE
- Market Cap
- QIPT 118.5M
- GUTS 98.7M
- IPO Year
- QIPT N/A
- GUTS 2024
- Fundamental
- Price
- QIPT $2.36
- GUTS $2.06
- Analyst Decision
- QIPT Strong Buy
- GUTS Buy
- Analyst Count
- QIPT 3
- GUTS 2
- Target Price
- QIPT $7.67
- GUTS $18.00
- AVG Volume (30 Days)
- QIPT 143.2K
- GUTS 482.6K
- Earning Date
- QIPT 12-16-2024
- GUTS 11-12-2024
- Dividend Yield
- QIPT N/A
- GUTS N/A
- EPS Growth
- QIPT N/A
- GUTS N/A
- EPS
- QIPT N/A
- GUTS N/A
- Revenue
- QIPT $244,231,000.00
- GUTS $97,000.00
- Revenue This Year
- QIPT $24.53
- GUTS N/A
- Revenue Next Year
- QIPT $3.69
- GUTS N/A
- P/E Ratio
- QIPT N/A
- GUTS N/A
- Revenue Growth
- QIPT 29.31
- GUTS N/A
- 52 Week Low
- QIPT $2.35
- GUTS $1.74
- 52 Week High
- QIPT $5.29
- GUTS $14.50
- Technical
- Relative Strength Index (RSI)
- QIPT 29.15
- GUTS 39.27
- Support Level
- QIPT $2.35
- GUTS $1.91
- Resistance Level
- QIPT $2.77
- GUTS $2.24
- Average True Range (ATR)
- QIPT 0.10
- GUTS 0.24
- MACD
- QIPT -0.03
- GUTS -0.05
- Stochastic Oscillator
- QIPT 3.23
- GUTS 14.41
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.